News
Eli Lilly and Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback